-
Product Insights
NewCardiac Ablation Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Cardiac Ablation Devices Pipeline Market Report Overview Cardiac ablation devices use radiofrequency energy to destroy cardiac tissues which propagate incorrect electrical signals to cause an abnormal heart rhythm. The cardiac ablation devices pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated...
-
Product Insights
NewCardiac Markers Rapid Tests and POC Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Cardiac Markers Rapid Tests and POC Pipeline Market Report Overview Cardiac markers rapid tests & point of care (POC) are simple to perform rapid diagnostic tests that are ready to use, accurate, economical, and for infield use. These tests are suggested for individuals suspected of any indication. The Cardiac Markers Rapid Tests and POC pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes...
-
Product Insights
Cardiac Arrest – Drugs In Development, 2023
Global Markets Direct’s, ‘Cardiac Arrest - Drugs In Development, 2023’, provides an overview of the Cardiac Arrest pipeline landscape. The report provides comprehensive information on the therapeutics under development for Cardiac Arrest, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Sector Analysis
Cardiac Valve Repair Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Cardiac Valve Repair Devices Market Report Overview The cardiac valve repair devices market size was $226.7 million in 2023. The market is expected to grow at a CAGR of more than 4% during 2023-2033. Cardiac valve repair devices are used in open-heart surgery to repair malfunctioning valves. Cardiac Valve Repair Devices Market Outlook, 2023-2033 ($ Million) Buy the Full Report for More Insights into the Cardiac Valve Repair Devices Market Forecast Download a Free Report Sample The Cardiac Valve Repair...
-
Sector Analysis
Cardiac Resynchronisation Therapy (CRT) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Cardiac Resynchronisation Therapy Market Report Overview The Cardiac Resynchronisation Therapy (CRT) market size was valued at $3.28 billion in 2023. The market is anticipated to grow at a CAGR of more than 5% from 2023 to 2033. CRT device is used to treat heart failure-induced conduction disturbances and ventricular dyssynchrony. When used in combination with stable, optimal medical therapy, CRT is designed to reduce symptoms and improve cardiac function by restoring the mechanical sequence of ventricular activation and contraction. CRT...
-
Product Insights
Cardiac Marker Tests Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Cardiac Marker Tests Pipeline Market Report Overview A cardiac marker test is a biomarker test used to diagnose cardiac diseases. The Cardiac Marker Tests pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key Segments ·       Other Cardiac...
-
Product Insights
NewLikelihood of Approval Analysis for Friedreich Ataxia
Overview How likely is it that the drugs in Friedreich Ataxia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Friedreich Ataxia Overview Friedreich’s ataxia (FA) is a neuromuscular disease that mainly...
-
Product Insights
NewLikelihood of Approval Analysis for Staphylococcal Infections
Overview How likely is it that the drugs in Staphylococcal Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Staphylococcal Infections Overview A staphylococcal infection or staph infection is an infection...
-
Product Insights
NewLikelihood of Approval Analysis for Systolic Heart Failure
Overview How likely is it that the drugs in Systolic Heart Failure will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Systolic Heart Failure Overview Systolic heart failure is a cardiovascular disorder...
-
Product Insights
NewLikelihood of Approval Analysis for Acute Heart Failure
Overview How likely is it that the drugs in Acute Heart Failure will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Acute Heart Failure Overview Acute heart failure (AHF) is a critical...